References
- UNAIDSAIDS Epidemic Update122009GenevaUNAIDS2009
- WHOTowards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector: Progress Report September 2009GenevaWorld Health Organization2009
- De CockKMGilksCFLoYRGuermaTCan antiretroviral therapy eliminate HIV transmission?Lancet200937396577919038440
- WoodETyndallMWSpittalPMFactors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programmeAIDS200216694194311919503
- MalonzaIMRichardsonBAKreissJKBwayoJJStewartGCThe effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trialAIDS200317111311812478076
- TemmermanMQuaghebeurAMwanyumbaFMandaliyaKMother-to-child HIV transmission in resource poor settings: how to improve coverage?AIDS20031781239124212819526
- GayleHDExpanding access to HIV preventionAIDS Res Ther20063216417638
- StoverJFahnestockMCoverage of Selected Services for HIV/AIDS Prevention, Care, and Treatment in Low- and Middle-Income Countries in 2005Washington (DC)Constella Futures, POLICY Project2006
- WilliamsBGLloyd-SmithJOGouwsEThe potential impact of male circumcision on HIV in sub-Saharan AfricaPLoS Med200637e26216822094
- Abdool KarimQAbdool KarimSSFrohlichJAEffectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in womenScience201032959961168117420643915
- WeissRASpecial anniversary review: twenty-five years of human immunodeficiency virus research: successes and challengesClin Exp Immunol2008152220121018373700
- Rerks-NgarmSPitisuttithumPNitayaphanSVaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in ThailandN Engl J Med2009361232209222019843557
- BunnellRMerminJde CockKMHIV prevention for a threatened continent: implementing positive prevention in AfricaJAMA2006296785585816905790
- HosseinipourMCohenMSVernazzaPLKashubaADCan antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1?Clin Infect Dis200234101391139511981736
- LevyARJamesDJohnstonKMThe direct costs of HIV/AIDS careLancet Infect Dis20066317117716500598
- GranichRMGilksCFDyeCde CockKMWilliamsBGUniversal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelLancet20093739657485719038438
- GilksCFCrowleySEkpiniRThe WHO public-health approach to antiretroviral treatment against HIV in resource-limited settingsLancet2006368953450551016890837
- StaszewskiSMorales-RamirezJTashimaKTEfavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 TeamN Engl J Med1999341251865187310601505
- GallantJEDeJesusEArribasJRTenofovir DF, emtricitabine, and efavirenz vs zidovudine, lamivudine, and efavirenz for HIVN Engl J Med2006354325126016421366
- Médecins Sans FrontièresUntangling the Web of Antiretroviral Price Reductions13th edMédecins Sans Frontières Report2010 Available from: http://utw.msfaccess.org/Accessed Dec 17 2010
- JahnAFloydSCrampinACPopulation-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in MalawiLancet200837196241603161118468544
- MurphyELCollierACKalishLAHighly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV diseaseAnn Intern Med20011351172611434728
- ViolariACottonMFGibbDMEarly antiretroviral therapy and mortality among HIV-infected infantsN Engl J Med2008359212233224419020325
- Velasco-HernandezJXGershengornHBBlowerSMCould widespread use of combination antiretroviral therapy eradicate HIV epidemics?Lancet Infect Dis20022848749312150848
- BunnellREkwaruJPSolbergPChanges in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural UgandaAIDS2006201859216327323
- BaggaleyRFGarnettGPFergusonNMModelling the impact of antiretroviral use in resource-poor settingsPLoS Med200634e12416519553
- KilbyJMLeeHYHazelwoodJDTreatment response in acute/ early infection versus advanced AIDS: equivalent first and second phases of HIV RNA declineAIDS200822895796218453855
- VernazzaPLGilliamBLFleppMEffect of antiviral treatment on the shedding of HIV-1 in semenAIDS19971110124912549256943
- GuptaPMellorsJKingsleyLHigh viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitorsJ Virol1997718627162759223532
- DunnDTNewellMLAdesAEPeckhamCSRisk of human immunodeficiency virus type 1 transmission through breastfeedingLancet199234088195855881355163
- WardJWHolmbergSDAllenJRTransmission of human immunodeficiency virus (HIV) by blood transfusions screened as negative for HIV antibodyN Engl J Med198831884734783422337
- CameronDWSimonsenJND’CostaLJFemale to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in menLancet1989286604034072569597
- QuinnTCWawerMJSewankamboNViral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study GroupN Engl J Med20003421392192910738050
- SperlingRSShapiroDECoombsRWMaternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study GroupN Engl J Med199633522162116298965861
- HoggRSRhoneSAYipBAntiviral effect of double and triple drug combinations amongst HIV-infected adults: lessons from the implementation of viral load-driven antiretroviral therapyAIDS19981232792849517990
- VernazzaPLGilliamBLDyerJQuantification of HIV in semen: correlation with antiviral treatment and immune statusAIDS19971189879939223732
- MarconiVCGranditsGAWeintrobACOutcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the US Military HIV Natural History StudyAIDS Res Ther2010711420507622
- HartCELennoxJLPratt-PalmoreMCorrelation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tractJ Infect Dis1999179487188210068582
- Cu-UvinSCaliendoAMReinertSEffect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNAAIDS200014441542110770544
- Centers for Disease Control and Prevention (CDC)Achievements in public health. Reduction in perinatal transmission of HIV infection – United States, 1985–2005MMWR Morb Mortal Wkly Rep2006552159259716741495
- European Collaborative StudyMother-to-child transmission of HIV infection in the era of highly active antiretroviral therapyClin Infect Dis200540345846515668871
- FangGBurgerHGrimsonRMaternal plasma human immunodeficiency virus type 1 RNA level: a determinant and projected threshold for mother-to-child transmissionProc Natl Acad Sci U S A1995922612100121048618852
- GuayLAMusokePFlemingTIntrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialLancet1999354918179580210485720
- De CockKMFowlerMGMercierEPrevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practiceJAMA200028391175118210703780
- TovanabutraSRobisonVWongtrakulJMale viral load and heterosexual transmission of HIV-1 subtype E in northern ThailandJ Acquir Immune Defic Syndr200229327528311873077
- PedrazaMAdel RomeroJRoldánFHeterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partnerJ Acquir Immune Defic Syndr199921212012510360803
- CastillaJdel RomeroJHernandoVMarincovichBGarcíaSRodríguezCEffectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIVJ Acquir Immune Defic Syndr20054019610116123689
- MusiccoMLazzarinANicolosiAAntiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Italian Study Group on HIV Heterosexual TransmissionArch Intern Med199415417197119768074601
- Van de VenPPrestageGCrawfordJGrulichAKippaxSSexual risk behaviour increases and is associated with HIV optimism among HIV-negative and HIV-positive gay men in Sydney over the 4 year period to February 2000AIDS200014182951295311153682
- Van de VenPKippaxSKnoxSPrestageGCrawfordJHIV treatments optimism and sexual behaviour among gay men in Sydney and MelbourneAIDS199913162289229410563714
- Centers for Disease Control and Prevention (CDC)Increases in unsafe sex and rectal gonorrhea among men who have sex with men – San Francisco, California, 1994–1997MMWR Morb Mortal Wkly Rep199948345489935141
- BlowerSMGershengornHBGrantRMA tale of two futures: HIV and antiretroviral therapy in San FranciscoScience2000287545365065410649998
- LawMGPrestageGGrulichAvan de VenPKippaxSModelling the effect of combination antiretroviral treatments on HIV incidenceAIDS200115101287129411426074
- BlowerSFarmerPPredicting the public health impact of antiretrovirals: preventing HIV in developing countriesAIDScience2003311 Available from: http://aidscience.org/Articles/AIDScience033.aspAccessed December 17, 2010
- FangCTHsuHMTwuSJDecreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in TaiwanJ Infect Dis2004190587988515295691
- CrepazNHartTAMarksGHighly active antiretroviral therapy and sexual risk behavior: a meta-analytic reviewJAMA2004292222423615249572
- BechangeSBunnellRAworATwo-year follow-up of sexual behavior among HIV-uninfected household members of adults taking antiretroviral therapy in Uganda: no evidence of disinhibitionAIDS Behav201014481682318949550
- VenkateshKKde BruynGLurieMNDecreased sexual risk behavior in the era of HAART among HIV-infected urban and rural South Africans attending primary care clinicsAIDS201024172687269620808202
- BlowerSBodineEKahnJMcFarlandWThe antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical modelsAIDS200519111415627028
- LawnSDHarriesADAnglaretXMyerLWoodREarly mortality among adults accessing antiretroviral treatment programmes in sub-Saharan AfricaAIDS200822151897190818784453
- BunnellROpioAMusinguziJHIV transmission risk behavior among HIV-infected adults in Uganda: results of a nationally representative surveyAIDS200822561762418317003
- HarriesADSchoutenEJLibambaEScaling up antiretroviral treatment in resource-poor settingsLancet200636795251870187216753490
- HoDDTime to hit HIV, early and hardN Engl J Med199533374504517616996
- PhillipsAMorbidity and mortality in the HAART era [abstract]15th Conference on Retroviruses and Opportunistic Infections (CROI 2008)2008 Feb 3–6Boston, MA, USA
- HargroveJWHumphreyJHMortality among HIV-positive postpartum women with high CD4 cell counts in ZimbabweAIDS2010243F11F1420095074
- MayRMAndersonRMThe transmission dynamics of human immunodeficiency virus (HIV)Philos Trans R Soc Lond B Biol Sci198832112075656072907158
- WilliamsBGKorenrompELGouwsESchmidGPAuvertBDyeCHIV infection, antiretroviral therapy, and CD4+ cell count distributions in African populationsJ Infect Dis2006194101450145817054076
- Cia.gov.c2007 Available from: https://www.cia.gov/Accessed Aug 19 2010
- AssefaYLeraMUniversal voluntary HIV testing and immediate antiretroviral therapy [correspondence]Lancet20093739669108019328998
- CohenJAIDS research. Treat everyone now? A ‘radical’ model to stop HIV’s spreadScience20083225907145319056948
- YuJKChenSCWangKYTrue outcomes for patients on antiretroviral therapy who are “lost to follow-up” in MalawiBull World Health Organ200785755055417768504
- MillsEJNachegaJBBuchanIAdherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysisJAMA2006296667969016896111
- FarmerPLéandreFMukherjeeJSCommunity-based approaches to HIV treatment in resource-poor settingsLancet2001358927940440911502340
- GarnettGPBaggaleyRFTreating our way out of the HIV pandemic: could we, would we, should we?Lancet2009373965791119038439
- Van LethFPhanuphakPRuxrungthamKComparison of first- line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN StudyLancet200436394171253126315094269
- YerlySJostSTelentiAInfrequent transmission of HIV-1 drug-resistant variantsAntivir Ther20049337538415259900
- RoutyJPMachoufNEdwardesMDFactors associated with a decrease in the prevalence of drug resistance in newly HIV-1 infected individuals in MontrealAIDS200418172305231215577543
- JürgensRCohenJTarantolaDHeywoodMCarrRUniversal voluntary HIV testing and immediate antiretroviral therapy [correspondence]Lancet200937396691079
- GranichRMGilksCFDyeCde CockKMWilliamsBGUniversal voluntary HIV testing and immediate antiretroviral therapy – author’s reply [correspondence]Lancet2009373966910801081
- CorbettELMarstonBChurchyardGJde CockKMTuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentLancet2006367951492693716546541
- WilliamsBGDyeCAntiretroviral drugs for tuberculosis control in the era of HIV/AIDSScience200330156391535153712920302